BBSRC Portfolio Analyser
Award details
The Role of CD45 Isoforms in Lymphocyte Signalling
Reference
BBS/E/E/0CD/1/00
Principal Investigator / Supervisor
Professor Peter Beverley
Co-Investigators /
Co-Supervisors
Dr D Alexander
Institution
Edward Jenner Institute for Vaccine Res
Department
Scientific Head
Funding type
Research
Value (£)
50,000
Status
Completed
Type
Institute Project
Start date
11/01/2001
End date
10/01/2004
Duration
36 months
Abstract
CD45 is a major surface molecule in all leucocytes and is a tyrosine phosphatase. This project will investigate the role of individual CD45 isoforms in regulating signals transduced by the T cell receptor and by the CD28 and CTLA-4 co- receptors. T cells from single isoform transgenic mice bred on to the knockout background will be used. The immunological phenotype and function of these mice will be assessed using immunofluorescence and flow cytometry, immunohistology, in vitro mitogen assays and immunisation with specific antigens. These data will be correlated with the results of signalling assays. Kinase regulation in thymocytes and peripheral T cells will be assayed by immunoblotting of precipitated kinases to assess phosphorylation status, in vitro assays of kinase immunoprecipitates, and studies of kinase TCR interactions. Interactions between CD45 isoforms and other cell surface molecules will be studied using Fluorescence Energy Resonance Transfer (FRET).
Summary
unavailable
Committee
Closed Committee - Biochemistry & Cell Biology (BCB)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search